Karlsson Linda C, Soveri Anna, Lewandowsky Stephan, Karlsson Linnea, Karlsson Hasse, Nolvi Saara, Karukivi Max, Lindfelt Mikael, Antfolk Jan
Department of Psychology, Åbo Akademi University, Finland.
FinnBrain Birth Cohort Study, Institute of Clinical Medicine, University of Turku, Finland.
Pers Individ Dif. 2021 Apr;172:110590. doi: 10.1016/j.paid.2020.110590. Epub 2020 Dec 14.
As studies indicate that people perceive COVID-19 as a threatening disease, the demand for a vaccine against the disease could be expected to be high. Vaccine safety concerns might nevertheless outweigh the perceived disease risks when an individual decides whether or not to accept the vaccine. We investigated the role of perceived risk of COVID-19 (i.e., perceived likelihood of infection, perceived disease severity, and disease-related worry) and perceived safety of a prospective vaccine against COVID-19 in predicting intentions to accept a COVID-19 vaccine. Three Finnish samples were surveyed: 825 parents of small children, 205 individuals living in an area with suboptimal vaccination coverage, and 1325 Facebook users nationwide. As points of reference, we compared the perceptions of COVID-19 to those of influenza and measles. COVID-19 was perceived as a threatening disease-more so than influenza and measles. The strongest predictor of COVID-19 vaccination intentions was trusting the safety of the potential vaccine. Those perceiving COVID-19 as a severe disease were also slightly more intent on taking a COVID-19 vaccine. Informing the public about the safety of a forthcoming COVID-19 vaccine should be the focus for health authorities aiming to achieve a high vaccine uptake.
由于研究表明人们将新冠病毒视为一种具有威胁性的疾病,可以预期对该疾病疫苗的需求会很高。然而,当个人决定是否接受疫苗时,对疫苗安全性的担忧可能会超过对疾病风险的认知。我们调查了对新冠病毒的感知风险(即感染的感知可能性、疾病严重程度的感知以及与疾病相关的担忧)以及对一种针对新冠病毒的前瞻性疫苗的感知安全性在预测接受新冠病毒疫苗意愿方面的作用。对三个芬兰样本进行了调查:825名幼儿家长、205名生活在疫苗接种覆盖率不理想地区的个人以及全国范围内的1325名脸书用户。作为参照,我们将对新冠病毒的认知与对流感和麻疹的认知进行了比较。新冠病毒被视为一种具有威胁性的疾病——比流感和麻疹更具威胁性。预测接种新冠病毒疫苗意愿的最强指标是信任潜在疫苗的安全性。那些认为新冠病毒是一种严重疾病的人也稍微更倾向于接种新冠病毒疫苗。对于旨在提高疫苗接种率的卫生当局来说,向公众宣传即将推出的新冠病毒疫苗的安全性应该是重点。